Search results for "Psoriatic arthritis"

showing 5 items of 55 documents

Ustekinumab therapy changes the transcriptional activity pattern of TGF-β1–3 genes

2019

Introduction One of the examples of genes whose expression can be altered by the action of ustekinumab is TGF-β. It is a pleiotropic cytokine whose activity affects psoriatic changes and the state of homeostasis of the whole organism. Aim To evaluate the effect of ustekinumab on the transcriptional activity of TGF-b family genes in patients with psoriatic arthritis and to check whether the results obtained can be helpful in monitoring the progress of treatment. Material and methods From total PBMCs obtained from peripheral blood of 14 patients with psoriatic arthritis, total RNA was isolated. The expression level of the TGF-β1, TGF-β2 and TGF-β3 genes was determined by RT-qPCR in real time.…

molecular markerMessenger RNAOriginal Paperbusiness.industrymedicine.medical_treatmentRNApsoriasis arthritisDermatologyPharmacologymedicine.diseasePeripheral blood mononuclear cellRC31-1245ustekinumabPsoriatic arthritisCytokineRL1-803UstekinumabmedicineImmunology and Allergytgfβ1-3businessGeneInternal medicinemedicine.drugTransforming growth factorAdvances in Dermatology and Allergology
researchProduct

Das Kiefergelenk bei entzündlichen, degenerativen und weichteilrheumatischen Erkrankungen

1991

Temporomandibular joint affections in rheumatic disease are described. They were seen in inflamed joint diseases, mostly in rheumatoid arthritis, and less so in juvenile rheumatoid arthritis, psoriatic arthritis, Reiter’s syndrome, ankylosing spondylitis, and collagen vascular disease.

musculoskeletal diseasesPathologymedicine.medical_specialtyAnkylosing spondylitisbusiness.industryRheumatic diseasemedicine.diseaseDermatologyTemporomandibular jointstomatognathic diseasesPsoriatic arthritismedicine.anatomical_structureRheumatoid arthritisCollagen vascular diseaseMedicineskin and connective tissue diseasesbusinessJuvenile rheumatoid arthritis
researchProduct

Non-healing tongue ulcer in a rheumatoid arthritis patient medicated with leflunomide. An adverse drug event?

2017

Leflunomide is a member of the disease modifying anti-rheumatic drugs group used as a treatment modality in active rheumatoid and psoriatic arthritis. “Oral ulcers” are reported in 3-5% of leflunomide medicated rheumatoid arthritis patients with adverse events, but they are not described in detail in the literature. We present a case of an ulcer in the tongue of a rheumatoid arthritis patient managed with leflunomide and contemplate on its pathogenesis. Key words:Leflunomide, oral ulcer, DHODH.

musculoskeletal diseasesmedicine.medical_specialtyCase ReportOdontologíaDisease030207 dermatology & venereal diseases03 medical and health sciencesPsoriatic arthritis0302 clinical medicineTonguemedicineOral ulcersskin and connective tissue diseasesAdverse effectGeneral DentistryLeflunomide030203 arthritis & rheumatologyOral Medicine and Pathologybusiness.industry:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludDermatology3. Good healthSurgerymedicine.anatomical_structureAdverse drug eventRheumatoid arthritisUNESCO::CIENCIAS MÉDICASbusinessmedicine.drugJournal of Clinical and Experimental Dentistry
researchProduct

Metabolomics: An Emerging Approach to Understand Pathogenesis and to Assess Diagnosis and Response to Treatment in Spondyloarthritis

2022

Spondyloarthritis (SpA) is a group of rheumatic diseases whose pathogenesis relies on a complex interplay between genetic and environmental factors. Over the last several years, the importance of the alteration of the gut microbiota, known as dysbiosis, and the interaction of bacterial products with host immunity have been highlighted as intriguing key players in SpA development. The recent advent of the so called “-omics” sciences, that include metabolomics, opened the way to a new approach to SpA through a deeper characterisation of the pathogenetic mechanisms behind the disease. In addition, metabolomics can reveal potential new biomarkers to diagnose and monitor SpA patients. The aim of…

psoriatic arthritisQH301-705.5MicrobiotaPsoriatic arthritibiomarkersMetabolomicBiomarkerGeneral MedicineGastrointestinal MicrobiomeAnkylosing spondylitistomatognathic diseasesankylosing spondylitisSpondyloarthritisSpondylarthritisDysbiosisHumansMetabolomicsSpondylitis AnkylosingBiology (General)Cells
researchProduct

Retinal Vascular Assessment in Psoriasis: A Multicenter Study

2021

PurposeTo investigate the vascular status of the macula in psoriasis patients without history of ocular inflammation by Optical Coherence Tomography Angiography (OCTA).MethodsThis prospective cross-sectional multicenter study included 55 psoriasis patients and 55 control healthy subjects. A complete eye examination and 6 mm × 6 mm OCTA imaging were performed. Retinal vascular status was evaluated by analyzing vascular density (VD) of superficial vascular plexus (superficial wVD) and deep vascular plexuses (deep wVD) in a 6 mm × 6 mm area and in foveal (superficial fVD and deep fVD) and parafoveal sectors (superficial pVD and deep pVD). In addition, foveal thickness (FT) and foveal avascular…

retinaIntraocular pressuremedicine.medical_specialtyvascular changesgenetic structuresmacula; optical coherence tomography angiography; psoriasis; retina; vascular changesoptical coherence tomography angiographylcsh:RC321-571030207 dermatology & venereal diseases03 medical and health scienceschemistry.chemical_compoundPsoriatic arthritis0302 clinical medicineOphthalmologyPsoriasisMedicinemaculalcsh:Neurosciences. Biological psychiatry. NeuropsychiatrypsoriasiOriginal ResearchRetinamedicine.diagnostic_testbusiness.industryGeneral NeuroscienceRetinalpsoriasisOptical coherence tomography angiographymedicine.diseaseeye diseasesmedicine.anatomical_structurechemistryMulticenter studyEye examination030221 ophthalmology & optometrysense organsbusinessNeuroscienceFrontiers in Neuroscience
researchProduct